On November 11, Clorox falls 4.02% in Regular Trading, trading at $102.35 per share, with turnover of $34.5199 million.

The move follows a recent post-earnings rally, but the latest market focus remains on management's indication that fiscal adjusted EPS is more likely to land near the low end of its $5.70 to $6.00 guidance range as cost pressure persists, tempering enthusiasm after a strong quarterly beat.

Clorox previously reported fiscal first-quarter adjusted EPS of $1.55, above the $1.07 consensus estimate, on revenue of $1.905 billion versus the expected $1.876 billion. After the report, several institutions lifted target prices, including to $98, $99 and $94, yet some analysts also warned that second-quarter profit could face meaningful pressure and that uncertainty around organic sales growth, inflation and margins remains unresolved.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)